| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 11 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Australia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Agriculture | |
| #5 | Measurement | |
| #6 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies | |
| #6 | Animal care | |
| #7 | Analysing materials | |
| #8 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bachmann Martin F | 18 |
| #2 | Maurer Patrik | 6 |
| #3 | Tissot Alain | 4 |
| #4 | Spohn Gunther | 4 |
| #5 | Renner Wolfgang A | 3 |
| #6 | Frey Peter | 2 |
| #7 | Staufenbiel Matthias | 2 |
| #8 | Ortmann Rainer | 2 |
| #9 | Fulurija Alma | 2 |
| #10 | Lueoend Rainer | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2013115189A1 | Use of Interleukin-1 Beta Mutein Conjugates in the Treatment of Diabetes | |
| US2011268740A1 | Fully human influenza M2 specific antibodies | |
| WO2004053137A2 | Method for protein production | |
| WO2004000351A1 | Packaged virus-like particles for use as adjuvants: method of preparation and use |